Methylprednisolone administration multiple sclerosis

It is in the systemic corticosteroid class of medications. With intravenous use or oral use: Not licensed for use by mouth for the treatment of multiple sclerosis relapse

2024-03-28
    Clonidine for ibs
  1. Currently, the cause of MS remains unknown
  2. doi: 10
  3. 6 mg/kg/day in three or four divided doses (3
  4. To compare both routes of methylprednisolone administration
  5. Patient's acceptance grade
  6. A 39‐year‐old woman
  7. DOI: 10
  8. CD006921
  9. 1100-a
  10. On the initial MRI, there was a total of 9
  11. DESCRIPTION